2011
Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)
Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Pharmacology Biochemistry And Behavior 2011, 101: 69-76. PMID: 22197710, PMCID: PMC3272148, DOI: 10.1016/j.pbb.2011.12.002.Peer-Reviewed Original ResearchConceptsHead-bobbing behaviourLysergic acid diethylamideReceptor antagonistEx vivoDimethoxy-4Acute drug injectionAcid diethylamideChronic drug treatmentBehavioral pharmacologyMechanism of actionReceptor binding propertiesDrug injectionDrug treatmentAnimal modelsReceptor activationBehavioral effectsClinical literatureReceptorsAntagonist ligandsNaïve rabbitsPharmacologyHallucinogensAntagonistAminopropaneVivo
2010
Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit, Romano et al.
Romano AG, Quinn JL, Li L, Dave KD, Schindler EA, Aloyo VJ, Harvey JA. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit, Romano et al. Psychopharmacology 2010, 212: 441-448. PMID: 20827462, DOI: 10.1007/s00213-010-2004-7.Peer-Reviewed Original ResearchConceptsDorsal hippocampusDevelopment of desensitizationD-lysergic acid diethylamideEyeblink conditioningChronic administrationAminopropane hydrochlorideLast infusionIntrahippocampal injectionReceptor agonistParenteral injectionSerotonin 5HippocampusTrace eyeblink conditioningAcid diethylamideReceptorsPavlovian conditioningConditioning sessionsVehicle controlInjectionAgonists
2008
Relationship between recovery of frontocortical 5HT2A receptor density and PI hydrolysis after chronic treatment
Schindler E, Aloyo V, Harvey J. Relationship between recovery of frontocortical 5HT2A receptor density and PI hydrolysis after chronic treatment. The FASEB Journal 2008, 22: 621-621. DOI: 10.1096/fasebj.22.2_supplement.621.Peer-Reviewed Original ResearchReceptor densityPI hydrolysisControl levelsRecovery periodRecovery daysChronic drug administrationDOI treatmentSerotonin2A receptorsAgonist DOIChronic treatmentLast injectionDrug AdministrationPharmacologic manipulationPhosphatidylinositol hydrolysisTime pointsVivo studiesFurther studiesTissue slicesDaysReceptorsTreatmentPeriodLevelsMajor signaling systemsAdministration